ADOCIA Announces Its Annual Results for 2021 and Presents an Update on Activities

A cash position of 15.2 million euros on December 31, 2021, strengthened to 28 million euros on March 28, 2022 Major technical advances in 2021: - The approval to enter Phase 3 in China for

Related Keywords

Germany ,Japan ,United States ,Paris ,France General ,France ,Boissel ,Rhôalpes ,China ,Puech ,Midi Pyrées ,French ,Chinese ,German ,Katherine Bowdish ,Biochaperone Lispram ,Claudia Mitchell ,Astellas Pharma ,Ahmad Haidar ,Olivier Soula ,Pierre Louis Germain ,Adocia Deputy ,Tonghua Dongbao ,French National Institute Of Industrial Property ,Mcgill University Canada ,Euronext ,Euronext Paris ,General Shareholder Meeting ,Chief Financial Officer ,Drug Evaluation ,Mcgill University ,Professor Fran ,Non Alcoholic Steatohepatitis ,Vester Finance ,Senior Vice President ,Portfolio Strategy ,French National Institute ,Industrial Property ,French Autorit ,Diabetes Med ,Their Cardiovascular ,Investors Relations ,Puech Pays ,Adocia ,Nnounces ,Nnual ,Results ,021 ,Presents ,Update ,Activities ,